BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 21885601)

  • 1. How I treat autoimmune lymphoproliferative syndrome.
    Rao VK; Oliveira JB
    Blood; 2011 Nov; 118(22):5741-51. PubMed ID: 21885601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in autoimmune lymphoproliferative syndromes.
    Madkaikar M; Mhatre S; Gupta M; Ghosh K
    Eur J Haematol; 2011 Jul; 87(1):1-9. PubMed ID: 21447005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Advances in the knowledge and management of autoimmune lymphoproliferative syndrome].
    Garrido Colino C
    An Pediatr (Barc); 2014 Feb; 80(2):122.e1-7. PubMed ID: 24055319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated Understanding of Autoimmune Lymphoproliferative Syndrome (ALPS).
    Li P; Huang P; Yang Y; Hao M; Peng H; Li F
    Clin Rev Allergy Immunol; 2016 Feb; 50(1):55-63. PubMed ID: 25663566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma.
    Kaya Z; Işık M; Oruklu N; Kirkiz S; Bağrıaçık EÜ; Allende LM; Díaz-Madroñero MJ; Ruiz-García R; Pınarlı FG; Göçün Uyar P; Koçak Ü
    Turk J Haematol; 2021 Jun; 38(2):145-150. PubMed ID: 33375216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune lymphoproliferative syndrome (ALPS). Case report and family history.
    Ries F; Ferster A; Rieux-Laucat F; Biwer A; Dicato M
    Bull Soc Sci Med Grand Duche Luxemb; 2010; (2):271-8. PubMed ID: 20882745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoimmune lymphoproliferative syndrome. Update and review].
    Suárez-Gutiérrez M; Yamazaki-Nakashimada MA; Espinosa S; Blancas-Galicia L; Lugo-Reyes SO; Álvarez-Cardona A
    Rev Alerg Mex; 2019; 66(4):456-473. PubMed ID: 32105427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of autoimmune lymphoproliferative syndrome associated with FAS gene mutations.
    Price S; Shaw PA; Seitz A; Joshi G; Davis J; Niemela JE; Perkins K; Hornung RL; Folio L; Rosenberg PS; Puck JM; Hsu AP; Lo B; Pittaluga S; Jaffe ES; Fleisher TA; Rao VK; Lenardo MJ
    Blood; 2014 Mar; 123(13):1989-99. PubMed ID: 24398331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
    George LA; Teachey DT
    Paediatr Drugs; 2016 Aug; 18(4):261-72. PubMed ID: 27139496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the management and understanding of autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT; Seif AE; Grupp SA
    Br J Haematol; 2010 Jan; 148(2):205-16. PubMed ID: 19930184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
    Paskiewicz A; Niu J; Chang C
    Autoimmun Rev; 2023 Nov; 22(11):103442. PubMed ID: 37683818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.
    Oliveira JB; Bleesing JJ; Dianzani U; Fleisher TA; Jaffe ES; Lenardo MJ; Rieux-Laucat F; Siegel RM; Su HC; Teachey DT; Rao VK
    Blood; 2010 Oct; 116(14):e35-40. PubMed ID: 20538792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of autoimmune lymphoproliferactive syndrome and literature review].
    Liu L; Hu J; Ma J; Li X; Li F; Li C
    Zhonghua Er Ke Za Zhi; 2014 Dec; 52(12):923-6. PubMed ID: 25619350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Autoimmune Lymphoproliferative Syndrome with Defective FAS or FAS-Ligand Functions.
    Rieux-Laucat F; Magérus-Chatinet A; Neven B
    J Clin Immunol; 2018 Jul; 38(5):558-568. PubMed ID: 29911256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary Immune Regulatory Disorders With an Autoimmune Lymphoproliferative Syndrome-Like Phenotype: Immunologic Evaluation, Early Diagnosis and Management.
    López-Nevado M; González-Granado LI; Ruiz-García R; Pleguezuelo D; Cabrera-Marante O; Salmón N; Blanco-Lobo P; Domínguez-Pinilla N; Rodríguez-Pena R; Sebastián E; Cruz-Rojo J; Olbrich P; Ruiz-Contreras J; Paz-Artal E; Neth O; Allende LM
    Front Immunol; 2021; 12():671755. PubMed ID: 34447369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the Spectrum of Immune Dysregulation Manifestations in Autoimmune Lymphoproliferative Syndrome and Autoimmune Lymphoproliferative Syndrome-like Disorders.
    Failing C; Blase JR; Walkovich K
    Rheum Dis Clin North Am; 2023 Nov; 49(4):841-860. PubMed ID: 37821199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune Lymphoproliferative Syndrome: An Overview.
    Matson DR; Yang DT
    Arch Pathol Lab Med; 2020 Feb; 144(2):245-251. PubMed ID: 30958694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Next Generation Sequencing for Detecting Somatic
    López-Nevado M; Docampo-Cordeiro J; Ramos JT; Rodríguez-Pena R; Gil-López C; Sánchez-Ramón S; Gil-Herrera J; Díaz-Madroñero MJ; Delgado-Martín MA; Morales-Pérez P; Paz-Artal E; Magerus A; Rieux-Laucat F; Allende LM
    Front Immunol; 2021; 12():656356. PubMed ID: 33995372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune checkpoint deficiencies and autoimmune lymphoproliferative syndromes.
    Gámez-Díaz L; Grimbacher B
    Biomed J; 2021 Aug; 44(4):400-411. PubMed ID: 34384744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expanding spectrum of the autoimmune lymphoproliferative syndromes.
    Oliveira JB
    Curr Opin Pediatr; 2013 Dec; 25(6):722-9. PubMed ID: 24240292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.